Challenger Limited Expands Its Strategic Relationship With MS&AD

Challenger Limited Expands Its Strategic Relationship With MS&AD

Investment management firm, Challenger Limited (ASX: CGF) has taken a significant step in supporting its strategy for growth in Australia and internationally by expanding its strategic relationship with MS&AD Insurance Group Holdings Inc, a leading Japanese insurance company.

In an announcement made on 26 March 2019, Challenger announced that it has further progressed its strategic relationship with MS&AD which will help both the companies to explore new growth opportunities for both groups.  [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Under the new arrangement, it will start a quota share reinsurance of US dollar-denominated annuities issued in the Japanese market by Mitsui Sumitomo Primary Life Insurance Company Limited (MS Primary), a subsidiary of MS&AD. Since November 2016, Challenger has partnered with MS Primary to reinsure Australian dollar-denominated annuity products.

It is expected that the quota share reinsurance will commence from 1 July 2019, subject to necessary approvals including regulatory, compliance and contractual requirements.

Challenger Life is going to get an annual amount of at least ¥50 billion (currently ~A$640 million) as reinsurance from MS Primary each year for a minimum of five years.

Japanese insurance company, MS&AD is also planning to increase its Challenger shareholding to more than 15% of issued capital and seek representation on the Challenger Limited Board and once MS&AD’s Challenger shareholding exceeds 15%, and the reinsurance of US dollar annuities with MS Primary has commenced, it will nominate one non-executive director to join the Challenger Limited Board.

Challenger Life has entered into a new agreement with MS Primary to commence reinsuring the US dollar version of the 20-year term product. Currently, Challenger is having around 15 percent of its fixed-income portfolio in US dollar assets and will hedge any residual foreign currency risk in relation to the agreement.

While commenting on the expansion of this strategic relationship between Challenger and MS&AD, Challenger’s CEO Mr. Richard Howes told that this announcement reflects the success of the strategic relationship between Challenger and MS&AD which started three years ago. He further told that this expanded alliance leverages the strengths of both businesses to create opportunities for continued growth.

While commenting on the same, MS&AD President and CEO Yasuyoshi Karasawa told that this expansion of MS&AD and Challenger relationship is going to cover a wider range of annuities.

In Japan, the foreign currency fixed annuity market is growing strongly. The market has increased by around 70% in the past three years and it now represents ¥3.6 trillion in annual sales. Recently, the relative attractiveness of US dollar annuities has increased which reflects the changes in the US and Australian interest rates. As a result, the mix of foreign currency annuity sales in Japan has shifted away from Australian to US dollar products.

In the past six months, the share price of Challenger decreased by 34% as on 25 March 2019 and it is trading at a PE multiple of 33.24x. CGF’s shares are trading at $7.865 with a market capitalization of circa $4.45 billion as on 26 March 2019 (12:58 PM).


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report